Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/19420862.2016.1180491 http://scihub22266oqcxt.onion/10.1080/19420862.2016.1180491 C4968089!4968089!27115842     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       MAbs 2016 ; 8 (5): 841-7 Nephropedia Template TP {{tp|p=27115842|t=2016. Extending the market exclusivity of therapeutic antibodies through dosage patents |pdf=|usr=}}{{27115842}} gab.com Text Extending the market exclusivity of therapeutic antibodies through dosage patents JO: MAbs http://www.kidney.de/pget.php?&tw=1&pmid=27115842 #FOAvip Dosage patents are one way to extend the market exclusivity of an approved drug beyond the lifetime of the patent that protects the drug as such. Dosage patents may help to compensate the applicant for the long period where the active pharmaceutical ingredient as such is already under patent prosecution, but not on the market yet, due to lengthy development and approval procedures. This situation erodes part of the time the drug is marketed under patent protection. Dosage patents filed at a later date can provide remedy for this problem. Examples of successful and unsuccesful attempts, and the reasons for the respective outcomes, are provided in this article. Twit Text FOAVip Extending the market exclusivity of therapeutic antibodies through dosage patents ????MAbs http://www.kidney.de/pget.php?&tw=1&pmid=27115842 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27115842 #FOAvip English Wikipedia <ref>{{Cite pmid|27115842}}</ref> Extending the market exclusivity of therapeutic antibodies through dosage patents #MMPMID27115842 Storz U MAbs 2016[Jul]; 8 (5): 841-7 PMID27115842show ga Dosage patents are one way to extend the market exclusivity of an approved drug beyond the lifetime of the patent that protects the drug as such. Dosage patents may help to compensate the applicant for the long period where the active pharmaceutical ingredient as such is already under patent prosecution, but not on the market yet, due to lengthy development and approval procedures. This situation erodes part of the time the drug is marketed under patent protection. Dosage patents filed at a later date can provide remedy for this problem. Examples of successful and unsuccesful attempts, and the reasons for the respective outcomes, are provided in this article. äExtending the market exclusivity of therapeutic antibodies through dos(epmc).pdf DeepDyve Pubget Overpricing